Medtronic – System for Endovascular Treatment of Thoracic Aortic Aneurysms :Receives FDA Approval of Talent Captivia

Open repair of a thoracic aortic aneurysm can be a huge undertaking requiring cardiopulmonary bypass, with all its associated risks and costs, and sometimes even complete circulatory arrest. Fortunately, in certain cases, depending on the location of the aortic defect, there is an alternative – endovascular repair through the femoral artery. Medtronic has once again pushed the envelope in performing this less-invasive procedure by receiving approval for the Captivia delivery system to be used with its Talent Thoracic Stent Graft.

During thoracic endovascular aortic repair (TEVAR), the Talent Captivia System is inserted into the femoral artery in the patient’s groin and moved up through blood vessels to the aorta. With the device at the site of the aneurysm, the physician expands the stent graft within the aorta, creating a new path for blood flow that reduces pressure on the bulge and the risk of rupture.

“The Captivia Delivery System’s tip capture mechanism is designed to provide excellent control of the stent graft during deployment to ensure that blood flow isn’t occluded into the nearby arteries,” said Dr. Edward Y. Woo, M.D., vice-chief and program director of vascular surgery and endovascular therapy for the University of Pennsylvania Hospital System. “This improvement to the delivery system also increases my confidence in the device’s deployment accuracy.”

Medtronic now offers the Talent Thoracic Stent Graft in longer lengths (up to 215 mm in total length) to accommodate the aortic anatomies of more patients. In addition to tip capture, the Captivia Delivery System features a hydrophilic coating to ease insertion into the femoral artery and navigation through the iliac arteries (around the pelvis) en route to the aorta.

“In partnership with physicians around the world, Medtronic stent grafts have been used to treat more than 180,000 patients with aortic disease or injury – more than all other manufacturers combined,” said Tony Semedo, vice president and general manager of Medtronic’s Endovascular Innovations business.

Medtronic is committed to advancing the treatment of coronary, peripheral, aortic and structural heart disease through collaboration with leading clinicians, researchers and scientists worldwide.


Related Posts Plugin for WordPress, Blogger...
Be Sociable, Share!

About the Author

has written 157 posts on this blog.

Copyright © 2018 Medical Technology & Gadgets Blog All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes